BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38704509)

  • 21. Association of C>U RNA Editing with Human Disease Variants.
    Mandloi S; Falls Z; Deng R; Samudrala R; Elkin PL
    Stud Health Technol Inform; 2020 Jun; 270():1205-1206. PubMed ID: 32570581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities.
    Langlois MA; Beale RC; Conticello SG; Neuberger MS
    Nucleic Acids Res; 2005; 33(6):1913-23. PubMed ID: 15809227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. APOBEC3A cytidine deaminase induces RNA editing in monocytes and macrophages.
    Sharma S; Patnaik SK; Taggart RT; Kannisto ED; Enriquez SM; Gollnick P; Baysal BE
    Nat Commun; 2015 Apr; 6():6881. PubMed ID: 25898173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of alpharetrovirus replication by a range of human APOBEC3 proteins.
    Wiegand HL; Cullen BR
    J Virol; 2007 Dec; 81(24):13694-9. PubMed ID: 17913830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. APOBEC3G/3A Expression in Human Immunodeficiency Virus Type 1-Infected Individuals Following Initiation of Antiretroviral Therapy Containing Cenicriviroc or Efavirenz.
    Covino DA; Purificato C; Catapano L; Galluzzo CM; Gauzzi MC; Vella S; Lefebvre E; Seyedkazemi S; Andreotti M; Fantuzzi L
    Front Immunol; 2018; 9():1839. PubMed ID: 30135687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual inhibitory effects of APOBEC family proteins on retrotransposition of mammalian endogenous retroviruses.
    Esnault C; Millet J; Schwartz O; Heidmann T
    Nucleic Acids Res; 2006; 34(5):1522-31. PubMed ID: 16537839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential inhibition of long interspersed element 1 by APOBEC3 does not correlate with high-molecular-mass-complex formation or P-body association.
    Niewiadomska AM; Tian C; Tan L; Wang T; Sarkis PT; Yu XF
    J Virol; 2007 Sep; 81(17):9577-83. PubMed ID: 17582006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Possible footprints of APOBEC3F and/or other APOBEC3 deaminases, but not APOBEC3G, on HIV-1 from patients with acute/early and chronic infections.
    Armitage AE; Deforche K; Welch JJ; Van Laethem K; Camacho R; Rambaut A; Iversen AK
    J Virol; 2014 Nov; 88(21):12882-94. PubMed ID: 25165112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutagenesis of apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, reveals distinct domains that mediate cytosine nucleoside deaminase, RNA binding, and RNA editing activity.
    MacGinnitie AJ; Anant S; Davidson NO
    J Biol Chem; 1995 Jun; 270(24):14768-75. PubMed ID: 7782343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2n.
    Refsland EW; Hultquist JF; Harris RS
    PLoS Pathog; 2012; 8(7):e1002800. PubMed ID: 22807680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unraveling the Enzyme-Substrate Properties for APOBEC3A-Mediated RNA Editing.
    Kim K; Shi AB; Kelley K; Chen XS
    J Mol Biol; 2023 Sep; 435(17):168198. PubMed ID: 37442413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficient deamination of 5-methylcytosines in DNA by human APOBEC3A, but not by AID or APOBEC3G.
    Wijesinghe P; Bhagwat AS
    Nucleic Acids Res; 2012 Oct; 40(18):9206-17. PubMed ID: 22798497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of APOBEC3 variation in a population of HIV-1 infected individuals in northern South Africa.
    Matume ND; Tebit DM; Gray LR; Turner SD; Rekosh D; Bessong PO; Hammarskjöld ML
    BMC Med Genet; 2019 Jan; 20(1):21. PubMed ID: 30660178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biochemical analysis of hypermutation by the deoxycytidine deaminase APOBEC3A.
    Love RP; Xu H; Chelico L
    J Biol Chem; 2012 Aug; 287(36):30812-22. PubMed ID: 22822074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transient overexpression of exogenous APOBEC3A causes C-to-U RNA editing of thousands of genes.
    Sharma S; Patnaik SK; Kemer Z; Baysal BE
    RNA Biol; 2017 May; 14(5):603-610. PubMed ID: 27149507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo.
    Beale RC; Petersen-Mahrt SK; Watt IN; Harris RS; Rada C; Neuberger MS
    J Mol Biol; 2004 Mar; 337(3):585-96. PubMed ID: 15019779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dancin' deaminase.
    Harris RS; Matsuo H
    Nat Struct Mol Biol; 2006 May; 13(5):380-1. PubMed ID: 16738602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein B mRNA editing enzyme catalytic polypeptide-like family genes activation and regulation during tumorigenesis.
    Gao J; Choudhry H; Cao W
    Cancer Sci; 2018 Aug; 109(8):2375-2382. PubMed ID: 29856501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strategy of Human Cytomegalovirus To Escape Interferon Beta-Induced APOBEC3G Editing Activity.
    Pautasso S; Galitska G; Dell'Oste V; Biolatti M; Cagliani R; Forni D; De Andrea M; Gariglio M; Sironi M; Landolfo S
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30045985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro deamination of cytosine to uracil in single-stranded DNA by apolipoprotein B editing complex catalytic subunit 1 (APOBEC1).
    Petersen-Mahrt SK; Neuberger MS
    J Biol Chem; 2003 May; 278(22):19583-6. PubMed ID: 12697753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.